Cergentis' Targeted Locus Amplification (TLA) Technology uniquely enables the targeted complete Next Generation Sequencing of any genomic locus in any genome of interest. TLA uses the physical proximity of nucleotides within a locus of interest as the basis of selection and requires just one primer pair complementary to a short locus specific sequence to amplify 10.000's of basepairs of surrounding sequence information. TLA based sequencing results in complete sequence information of a locus of interest and the detection of all Single Nucleotide Variants & Structural Variants. Furthermore, TLA allows for haplotyping. Cergentis provides kits and services.